PURSUANT TO FEDERAL ACQUISITION REGULATION (FAR) 52.217-9, OPTION TO EXTEND THE TERM OF THE CONTRACT, W81K0…
Award details are derived from public USAspending.gov records. Not a bid recommendation.
Award details
- Award ID
- W81K0024P0152
- Contractor
- ALBA BIOSCIENCE, INC.
- Awarding agency
- Department of Defense
- Sub-agency / office
- Department of the Army
- Award amount
- $163,203
- Period of performance
- Oct 1, 2024 – Sep 30, 2025
- NAICS
- 325413 — In-Vitro Diagnostic Substance Manufacturing
- PSC
- PSC 6505
- Place of performance
- JBSA FT SAM HOUSTON, TX, 782344404, USA
- Competition
- COMPETED UNDER SAP · Set-aside: SMALL BUSINESS SET ASIDE - TOTAL · 2 offers
- Pricing
- FIRM FIXED PRICE
- Financial breakdown
- Current value $163,203 · Obligated $76,748 · Potential value $422,568 · Latest action obligation $0
Public award description
PURSUANT TO FEDERAL ACQUISITION REGULATION (FAR) 52.217-9, OPTION TO EXTEND THE TERM OF THE CONTRACT, W81K00-24-P-0152 WITH ALBA BIOSCIENCE, INC., IS HEREBY EXTENDED FOR THE PERIOD 01 OCTOBER 2025 - 30 SEPTEMBER 2026 (OPTION YEAR 1).
Find out who's winning similar federal contracts
Discover comparable awards, related contractors, and agency purchasing history.